*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and others’ efforts to overcome resistance to PD-1 therapy as well as insights into the role of dendritic cells.
Day 3 of AACR18 highlighted potentially “practice-changing” immunotherapy breakthroughs in lung cancer, and insights into the factors governing immunotherapy’s effectiveness in several other cancer types